Financial statements Advanced Biocomponents Poland

Balance sheet of Advanced Biocomponents Poland

Company age:
Age:
4 y. 11 m. 6 d.
Share capital:
Share capital:
200 000 PLN

Balance sheet data of ADVANCED BIOCOMPONENTS POLAND

Year
2020
2021
2022
Total assets 589 968,43 1 102 030,77 987 867,02
A. Fixed assets 13 144,31 7 705,31 31 534,61
B. Current assets 576 824,12 1 094 325,46 956 332,41
C. Share capital contributions (basic funds) 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00
Total liabilities 589 968,43 1 102 030,77 987 867,02
A. Equity 551 718,25 891 750,98 840 084,38
B. Liabilities and provisions for liabilities 38 250,18 210 279,79 147 782,64
I. Long-term liabilities 0,00 0,00 0,00
II. Short-term liabilities 38 250,18 210 279,79 147 782,64
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.